BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-84

  1. 16,311 Posts.
    lightbulb Created with Sketch. 4359
    You realise this is quite common right? In fact, for 510ks it's actually very normal

    FDA are incredibly bureaucratic, slow and inefficient. Even for the most experienced healthcare consultants and big pharma companies, it's tough to meet the vague but rigorous requirements on the first go
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.